Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 6/20 | 0.48 |
| ▸ | TOP1 | P11387 | 4/20 | 0.44 |
| ▸ | CYCS | P99999 | 3/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31612941 | 0.91 | TERT (0.56) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL3476670 | 0.91 | TERT (0.56) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL5013677 | 0.85 | TERT (0.41) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL28061934 | 0.82 | STAT3 (0.45) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL5013770 | 0.81 | TERT (0.44) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL30831251 | 0.81 | TERT (0.44) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL30831234 | 0.81 | TOP1 (0.46) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL15943807 | 0.80 | TOP1 (0.54) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL5011842 | 0.80 | TOP1 (0.54) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL242168 | 0.79 | TERT (0.62) | TERTTOP1CYCSABCG2ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210387994-A1 | SOLVENT-FREE CROSS-COUPLING REACTION, AND PRODUCTION METHOD USING SAID REACTION | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2021-12-16 | — | — | US | disclosed |
| WO-2020085396-A1 | SOLVENT-FREE CROSS-COUPLING REACTION, AND PRODUCTION METHOD USING SAID REACTION | 国立大学法人北海道大学 | 2020-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210387994-A1 | SOLVENT-FREE CROSS-COUPLING REACTION, AND PRODUCTION METHOD USING SAID REACTION | MCCC2, CTRC, DDC | TERT 1747/4885TOP1 1888/4885CYCS 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.